Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Takahiro Jinbo
Prognostic Importance of the Soluble Form of IL-2 Receptor^|^alpha; (sIL-2R^|^alpha;) and Its Relationship With Surface Expression of IL-2R^|^alpha; (CD25) of Lymphoma Cells in Diffuse Large B-Cell Lymphoma Treated With CHOP-like Regimen With or Without Rituximab : A Retrospective Analysis of 338 Cases
Journal of clinical and experimental hematopathology : JCEH
Medicine
Training of Robotic Surgery
Journal of Japan Society of Computer Aided Surgery
Related publications
The Interleukin 2 Receptor (IL-2R): The IL-2R Alpha Subunit Alters the Function of the IL-2R Beta Subunit to Enhance IL-2 Binding and Signaling by Mechanisms That Do Not Require Binding of IL-2 to IL-2R Alpha Subunit.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab and CHOP
Pathology and Oncology Research
Medicine
Forensic Medicine
Pathology
Oncology
Cancer Research
MELK Serves as a Potent Independent Biomarker to Predict Survival of Diffuse Large B-Cell Lymphoma Patients Treated With Rituximab-Chop Regimen
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Tumor Necrosis as a Prognostic Factor of Diffuse Large B-Cell Lymphoma Treated With R-Chop Therapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Response of Diffuse Large B-Cell Lymphoma Treated With R-Chop and Prognostic Factors Associated: A Single Institution Analysis in Lima, Peru
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Prognostic Significance of Ki67 and Its Correlation With Mitotic Index in Dogs With Diffuse Large B-Cell Lymphoma Treated With 19-Week CHOP-based Protocol
Journal of Veterinary Diagnostic Investigation
Veterinary
PROGNOSTIC FACTORS (PFs) IN PRIMARY MEDIASTINAL LARGE B-Cell LYMPHOMA (PMLBCL) TREATED WITH RITUXIMAB-CHOP (RCHOP) ± RADIOTHERAPY (RT)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Identification of Gene Modules Associated With Survival of Diffuse Large B-Cell Lymphoma Treated With CHOP-based Chemotherapy
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
Diffuse Large B-Cell Lymphoma Presenting With Gastrocolic Fistula and Successfully Treated With R-Chop Chemotherapy
Tenri Medical Bulletin
